Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06115070

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits (ALLOW)

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions Acute Ischemic Stroke (AIS) Thrombosis

Interventions Intravenous thrombolysis (alteplase and other guideline-recommended thrombolytic agents)

Updated 5 times since 2023 Last updated: Mar 5, 2025 Started: Mar 1, 2025 Primary completion: Dec 31, 2027 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06115070, this PHASE4 trial focuses on Acute Ischemic Stroke (AIS) and Thrombosis and remains actively recruiting participants. Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University, it has been updated 5 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Apr 2025 — Present [monthly]

Not Yet Recruiting PHASE4

Status: Recruiting → Not Yet Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Dec 2023 — Apr 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China